US2023165291A1PendingUtilityA1

Mitigation of chronic infant malnutrition

Assignee: QUINTESSENCE NUTRACEUTICALS LLCPriority: Sep 15, 2010Filed: Dec 12, 2022Published: Jun 1, 2023
Est. expirySep 15, 2030(~4.1 yrs left)· nominal 20-yr term from priority
A23V 2002/00A23L 33/40A23D 9/00A23L 33/15
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are nutraceutical formulations, and methods of using these nutraceutical formulations for the mitigation of chronic malnutrition in an infant, wherein the infant is breast feeding from a lactating mother ingesting one or more of said nutraceutical formulations in accordance with a prescribed regimen.

Claims

exact text as granted — not AI-modified
1 . A method of mitigation chronic malnutrition in an infant, the method comprising the infant breast feeding from a lactating mother ingesting a nutraceutical comprising a hydrophilic soluble fraction/lipophilic fiber fraction blend, wherein the hydrophilic soluble fraction/lipophilic fiber fraction blend ratio is from 1.2 to 1.4, and wherein said lactating mother has an initial body mass index of less than 25, and wherein said infant at the start of breast feeding has a weight of from 3 kg to 4 kg. 
     
     
         2 . The method of  claim 1 , wherein said lactating mother is ingesting from 35 grams per day to 45 grams per day of said nutraceutical. 
     
     
         3 . The method of  claim 1 , wherein said infant showed a monthly weight gain of from 500 grams per month to 800 grams per month in the first 12 months of starting said breast feeding.

Join the waitlist — get patent alerts

Track US2023165291A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.